Bronchobos syrup 250 mg / 5 ml fl. 200ml
Category
Thinning phlegm
,
Expectorants
Scope of the drug
Respiratory system
Release form
Syrup
Manufacturer country
Bosnia and Herzegovina
Package quantity, pcs
one
Release form, composition and packaging
?
Syrup 5% in the form of a transparent slightly viscous liquid from pink to red, with a raspberry scent.
5 ml (1 measuring spoon)
carbocisteine 250 mg
glycerol - 135 mg, ethanol 96% - 125 mg, sodium hydroxide - 61 mg, sodium carmellose - 20 mg, citric acid monohydrate - 10 mg, methyl parahydroxybenzoate - 9 mg, sodium saccharinate - 5 mg, propyl parahydroxybenzoate - 1 mg, raspberry flavor - 0.7 mg, azorubin CI14720 (E122) - 0.05 mg, purified water - up to 5 ml.
200 ml - dark glass bottles (1) complete with a measuring spoon with marked labels 2.5 ml and 5 ml - cardboard packs.
pharmachologic effect
Mucolytic and expectorant drug.
Mucolytic and expectorant action is due to the activation of sialic transferase - an enzyme of the goblet cells of the bronchial mucosa.
Normalizes the quantitative ratio of acidic and neutral sialomucins of bronchial secretions.
Reduces the viscosity of bronchial secretions and discharge from the paranasal sinuses, facilitates the discharge of sputum and mucus, and reduces coughing.
Promotes regeneration of the mucous membrane, normalizes its structure, activates the activity of the ciliated epithelium.
Restores the secretion of IgA immunoglobulin (specific protection) and the number of sulfhydryl groups of mucus components (non-specific protection), improves mucociliary clearance.
Pharmacokinetics
Absorption and distribution Carbocisteine is rapidly absorbed after oral administration.
Bioavailability is low (less than 10% of the dose taken).
Cmax in blood serum and in the mucous membrane of the respiratory tract is achieved 2-3 hours after ingestion of the drug and remains in the mucous membrane for 8 hours. Metabolism and excretion Metabolized in the liver (has the effect of first passage" through the liver).
It is excreted mainly by the kidneys, partly unchanged, partly in the form of metabolites.
T1 / 2 - about 2 hours
Indications for use
- acute and chronic bronchopulmonary diseases, accompanied by the formation of viscous, difficult to separate sputum (tracheitis, bronchitis, tracheobronchitis, bronchial asthma, bronchiectasis)
- inflammatory diseases of the middle ear (otitis media)
- inflammatory diseases of the nose and its paranasal sinuses (rhinitis, sinusitis)
- preparation for bronchoscopy and / or bronchography.
Contraindications for use
- hypersensitivity to carbocisteine and other components of the drug
- peptic ulcer of the stomach and duodenum in the acute phase
- chronic glomerulonephritis in the acute phase
- cystitis
- liver disease (for taking syrup)
- alcoholism (for taking syrup)
- epilepsy (for taking syrup)
- trauma or diseases of the brain (for taking syrup)
- pregnancy
- lactation (breastfeeding)
- children's age up to 3 years (for taking syrup 2.5%)
- children under 15 years of age (for taking capsules and syrup 5%).
With caution: with chronic glomerulonephritis (in history), gastric ulcer and duodenal ulcer (in history), in II-III trimesters of pregnancy and during breastfeeding.
Dosage regimen
The drug is administered orally.
Capsules Adults and adolescents over 15 years of age: 750 mg (2 capsules) 3 times / day.
After reaching the therapeutic effect, the daily dose is reduced to 1.5 g: 750 mg (2 capsules) 2 times / day.
Treatment should not be continued for more than 8-10 days without consulting a doctor.
Syrup To dose the syrup, use a 5 ml measuring spoon, graduated to 2.5 ml.
1 scoop of 5% syrup (5 ml) = 250 mg carbocysteine
1 scoop of syrup 2.5% (5 ml) = 125 mg carbocisteine Adults: 15 ml (3 scoops) of 5% syrup 3 times / day.
Children aged 3-6 years: 5 ml (1 scoop) 2.5% syrup 2-4 times / day.
Children over the age of 6: 5-10 ml (1-2 scoops) 2.5% syrup
Name ENG
BRONCHOBOS
Clinical and pharmacological group
Mucolytic drug
ATX code
Carbocisteine
Dosage
250mg / 5ml x 200ml
Structure
5 ml of syrup contains: Active ingredient: carbocisteine 250 mg
Excipients: glycerol 135 mg
ethanol 96% 125 mg
sodium hydroxide 61 mg
carmellose sodium 20 mg
citric acid monohydrate 10 mg
methyl parahydroxybenzoate 9 mg
sodium saccharinate 5 mg
propyl parahydroxybenzoate 1 mg
raspberry flavor 0.7 mg
azorubin CI 14720 (E122) 0.05 mg
purified water up to 5 ml.
Indications
acute and chronic bronchopulmonary diseases, accompanied by a violation of the formation and excretion of mucus (tracheitis, bronchitis, tracheobronchitis, bronchial asthma, bronchiectasis)
inflammatory diseases of the middle ear and paranasal sinuses (rhinitis, otitis media, sinusitis)
preparation of the patient for bronchoscopy or bronchography.
Contraindications
hypersensitivity to the drug or its auxiliary components
peptic ulcer of the stomach and duodenum in the acute stage
chronic glomerulonephritis (in the acute phase)
cystitis
children under 15 years old
liver disease
alcoholism
epilepsy
brain injury or disease
pregnancy
lactation.,
With care: gastric ulcer and duodenal ulcer (in history).
Storage conditions and periods
At a temperature not higher than 30 degrees.
(do not freeze).
Expiration date: 3 years
INN / Active ingredient
carbocisteine
Specifications
Category
Thinning phlegm
,
Expectorants
Scope of the drug
Respiratory system
Release form
Syrup
Manufacturer country
Bosnia and Herzegovina
Package quantity, pcs
one
Scope of application
Virology
Minimum age from
18 years
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Shelf life after opening
1 month
Brand name
Bosnalek +
Components
measuring spoon
The amount of the dosage form in the primary package
200 ml
Primary packaging type
Bottle
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Expectorant mucolytic agent
Anatomical and therapeutic characteristics
R05CB03 Carbocisteine
Dosage form
Syrup
Expiration date in days
1095
Dosage (volume) of the substance in the preparation
carbocisteine 250 mg
Package weight, g
425
Mode of application
:
Inside. < br> For the dosage of the syrup, a 5 ml measuring spoon is used, graduated to 2.5 ml.
1 scoop of syrup 5% (5 ml) = 250 mg of carbocisteine 1 scoop of syrup 2.5% (5 ml) = 125 mg of carbocysteine. < br> Adults - 15 ml (3 scoops) of 5% syrup 3 times day.
Information on technical characteristics, delivery set, country of manufacture "